菲诺利单抗联合贝伐珠单抗用于晚期肝细胞癌一线治疗的经济学评价
尹安桐, 李静, 王亚华, 智勇刚
Economic evaluation of finotonlimab combined with bevacizumab as first-line treatment for advanced hepatocellular carcinoma
YIN Antong, LI Jing, WANG Yahua, ZHI Yonggang
中国医院药学杂志
.
2026, (17): 2019
-2025
.
DOI: 10.13286/j.1001-5213.2026.17.08
